Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells

FEBS Letters

Volumn 409, Issue 1, 1997, Pages 17-23

  Wagenknecht, Bettina ^a   Gulbins, Erich ^a   Lang, Florian ^a   Dichgans, Johannes ^a   Weller, Michael ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; Arachidonic acid; CD95; Glioma; Lipoxygenase; Nordihydroguaretic acid

Indexed keywords

1,6 HEXAMETHYLENEDICARBAMIC ACID BIS(CYCLOHEXANONE OXIME) ESTER; ACETYLCYSTEINE; ARACHIDONIC ACID; ARISTOLOCHIC ACID; BUTYLCRESOL; CYCLOHEXIMIDE; DEXAMETHASONE; ESCULETIN; FAS ANTIGEN; INDOMETACIN; LIGAND; LIPOPROTEIN LIPASE; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MEPACRINE; N TERT BUTYL ALPHA PHENYLNITRONE; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; SUPEROXIDE DISMUTASE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ANIMAL CELL; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CULTURE; CELL LINE; COCULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ARACHIDONIC ACID; FAS LIGAND PROTEIN; GLIOMA; HUMANS; LIGANDS; LIPOXYGENASE INHIBITORS; MEMBRANE GLYCOPROTEINS; MICE; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030914835     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00468-7     Document Type: Article

References (34)

1. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S.I., Sameshima M., Hase A., Seto Y., Nagata S. Cell. 66:1991;233-243.
2. Heller R.A., Krönke M. J. Cell Biol. 126:1994;5-9.
3. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. Cell. 81:1995;505-512.
4. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. Cell. 85:1996;817-827.
5. Kolesnick R.N., Haimovitz-Friedman A., Fuks Z. Biochem. Cell Biol. 72:1994;471-474.
6. Cifone M.G., Roncaioli P., De Maria R., Camarda G., Santoni A., Ruberti G., Testi R. EMBO J. 14:1995;5859-5868.
7. Ratter F., Germer M., Fischbach T., Schulze-Osthoff K., Peter M., Dröge W., Krammer P.H., Lehmann V. Int. Immunol. 8:1996;1139-1147.
8. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., Kolesnick R.N. Nature. 380:1996;75-79.
9. Gulbins E., Bissonnette R., Mahboubi A., Martin S., Nishioka W., Brunner T., Baier G., Baier-Bitterlich G., Byrd C., Lang F., Kolesnick R., Altman A., Green D. Immunity. 2:1995;341-351.
10. Ballou L.R., Laulederkind S.J., Rosloniec E.F., Raghow R. Biochim. Biophys. Acta. 1301:1996;273-287.
11. Hsu H., Shu H.B., Pan M.P., Goeddel D.V. Cell. 84:1996;299-308.
12. Mathias S., Dressler K.A., Kolesnick R.N. Proc. Natl. Acad. Sci. USA. 88:1991;10009-10013.
13. Miura M., Friedländer R.M., Yuan J. Proc. Natl. Acad. Sci. USA. 92:1995;8318-8322.
14. Trent J.C., McConkey D.J., Loughlin S.M., Harbison M.T., Fernandez A., Ananthaswamy H.N. EMBO J. 15:1996;4497-4505.
15. Belka C., Wiegmann K., Adam D., Holland R., Neuloh M., Herrmann F., Krönke M., Brach M.A. EMBO J. 14:1995;1156-1165.
16. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., Tsujimoto M. J. Biol. Chem. 268:1993;11290-11295.
17. Enari M., Hug H., Hayakawa M., Ito F., Nishimura Y., Nagata S. Eur. J. Biochem. 236:1996;533-538.
18. Haliday E.M., Ramesha C.S., Ringold G. EMBO J. 10:1991;109-115.
19. O'Donnel V.B., Spycher S., Azzi A. Biochem. J. 310:1995;133-141.
20. Sandstrom P.A., Tebbey P.W., Van Cleave S., Buttke T.M. J. Biol. Chem. 269:1994;798-801.
21. Weller M., Frei K., Groscurth P., Krammer P.H., Yonekawa Y., Fontana A. J. Clin. Invest. 94:1994;954-964.
22. Weller M., Malipiero U., Aguzzi A., Reed J.C., Fontana A. J. Clin. Invest. 95:1995;2633-2643.
23. Weller M., Malipiero U., Rensing-Ehl A., Barr P.J., Fontana A. Cancer Res. 55:1995;2936-2944.
24. Rensing-Ehl A., Frei K., Flury R., Matiba B., Mariani S.M., Weller M., Aebischer P., Krammer P.H., Fontana A. Eur. J. Immunol. 25:1995;2253-2258.
25. Weller M., Constam D.B., Malipiero U., Fontana A. Eur. J. Immunol. 24:1994;1293-1300.
26. Schulz J.B., Weller M., Klockgether T. J. Neurosci. 16:1996;4696-4706.
27. Bligh E.G., Dyer W.J. Can. Biochem. J. Physiol. 37:1959;911-917.
28. Blomgren H., Kling-Andersson G. Anticancer Res. 12:1992;981-986.
29. Wilson D.E., DiGianfilippo A., Ondrey F.G., Anderson K.M., Harris J.E. J. Neurosurg. 71:1989;551-557.
30. Jäättelä M., Benedict M., Tewari M., Shayman J.A., Dixit V.M. Oncogene. 10:1995;2297-2305.
31. Weller, M., Schmidt, C., Roth, W. and Dichgans, J. (1997) Neurology, in press.
32. Goddard D.H., Bomalaski J.S., Lipper S., Shorr R.G., Clark M.A. Cancer Lett. 102:1996;1-6.
33. Schulze-Osthoff K., Krammer P.H., Dröge W. EMBO J. 13:1994;4587-4596.
34. Hug H., Enari M., Nagata S. FEBS Lett. 351:1994;311-313.